-+ 0.00%
-+ 0.00%
-+ 0.00%

AKESO ANNOUNCES OPENING OF GLOBAL PHASE II STUDY OF IVONESCIMAB IN FIRST-LINE CLEAR CELL RENAL CELL CARCINOMA, INCLUDING COMBINATION WITH CADONILIMAB

Reuters·10/19/2026 12:01:06

Please log in to view news